| - GRCh37:
- Chr3:10107562
- GRCh38:
- Chr3:10065878
| FANCD2, LOC107303338 | L725V, L762V | Fanconi anemia complementation group D2 | Uncertain significance (Sep 29, 2022) | criteria provided, single submitter |
| - GRCh37:
- Chr3:10102050
- GRCh38:
- Chr3:10060366
| FANCD2, LOC107303338 | G540S, G577S | Fanconi anemia complementation group D2 | Uncertain significance (Jul 17, 2019) | criteria provided, single submitter |
| - GRCh37:
- Chr3:10094150
- GRCh38:
- Chr3:10052466
| LOC107303338, FANCD2 | S542N | Fanconi anemia complementation group D2 | Uncertain significance (Nov 20, 2019) | criteria provided, single submitter |
| - GRCh37:
- Chr3:10107626
- GRCh38:
- Chr3:10065942
| FANCD2, LOC107303338 | C746F, C783F | Fanconi anemia complementation group D2 | Uncertain significance (Oct 19, 2020) | criteria provided, single submitter |
| - GRCh37:
- Chr3:10132005
- GRCh38:
- Chr3:10090321
| FANCD2, FANCD2OS | M1201K, M1238K | Fanconi anemia complementation group D2 | Uncertain significance (Sep 27, 2022) | criteria provided, single submitter |
| - GRCh37:
- Chr3:10114928
- GRCh38:
- Chr3:10073244
| FANCD2, LOC107303338 | | Fanconi anemia complementation group D2 | Uncertain significance (Sep 27, 2022) | criteria provided, single submitter |
| - GRCh37:
- Chr3:10128819
- GRCh38:
- Chr3:10087135
| FANCD2OS, FANCD2 | Q1076*, Q1113* | Fanconi anemia complementation group D2 | Likely pathogenic (Sep 1, 2022) | criteria provided, single submitter |
| - GRCh37:
- Chr3:10142887
- GRCh38:
- Chr3:10101203
| FANCD2, FANCD2OS | E1396K, E1433K | Fanconi anemia, Fanconi anemia complementation group D2 | Uncertain significance (Feb 1, 2022) | criteria provided, multiple submitters, no conflicts |
| - GRCh37:
- Chr3:10081443
- GRCh38:
- Chr3:10039759
| FANCD2, LOC107303338 | | Fanconi anemia complementation group D2, Fanconi anemia | Likely benign (Sep 22, 2022) | criteria provided, multiple submitters, no conflicts |
| - GRCh37:
- Chr3:10138134
- GRCh38:
- Chr3:10096450
| FANCD2, FANCD2OS | N1351S, N1375S, N1388S | Fanconi anemia, Fanconi anemia complementation group D2 | Uncertain significance (May 3, 2022) | criteria provided, multiple submitters, no conflicts |
| - GRCh37:
- Chr3:10107165
- GRCh38:
- Chr3:10065481
| LOC107303338, FANCD2 | | Fanconi anemia, Fanconi anemia complementation group D2 | Likely benign (May 19, 2022) | criteria provided, multiple submitters, no conflicts |
| - GRCh37:
- Chr3:10094126
- GRCh38:
- Chr3:10052442
| LOC107303338, FANCD2 | Y534F | Fanconi anemia, Fanconi anemia complementation group D2 | Uncertain significance (Aug 23, 2022) | criteria provided, multiple submitters, no conflicts |
| - GRCh37:
- Chr3:10132070
- GRCh38:
- Chr3:10090386
| FANCD2, FANCD2OS | | Fanconi anemia complementation group D2 | Pathogenic (May 4, 2022) | criteria provided, single submitter |
| - GRCh37:
- Chr3:10089600
- GRCh38:
- Chr3:10047916
| FANCD2, LOC107303338 | | Fanconi anemia complementation group D2 | Pathogenic (May 4, 2022) | criteria provided, single submitter |
| - GRCh37:
- Chr3:10076499
- GRCh38:
- Chr3:10034815
| FANCD2, LOC107303338 | | Hereditary breast ovarian cancer syndrome, Fanconi anemia complementation group D2, Fanconi anemia
| Likely benign (Sep 20, 2022) | criteria provided, multiple submitters, no conflicts |
| - GRCh37:
- Chr3:10076133
- GRCh38:
- Chr3:10034449
| FANCD2, LOC107303338 | | Hereditary breast ovarian cancer syndrome, Fanconi anemia complementation group D2, Fanconi anemia
| Likely benign (Apr 19, 2022) | criteria provided, multiple submitters, no conflicts |
| - GRCh37:
- Chr3:10136058
- GRCh38:
- Chr3:10094374
| FANCD2, FANCD2OS | | Fanconi anemia, Fanconi anemia complementation group D2 | Likely benign (Sep 23, 2021) | criteria provided, multiple submitters, no conflicts |
| - GRCh37:
- Chr3:10084725
- GRCh38:
- Chr3:10043041
| FANCD2, LOC107303338 | | Fanconi anemia complementation group D2, Fanconi anemia | Likely benign (May 20, 2022) | criteria provided, multiple submitters, no conflicts |
| - GRCh37:
- Chr3:10081386
- GRCh38:
- Chr3:10039702
| FANCD2, LOC107303338 | | Fanconi anemia, Fanconi anemia complementation group D2 | Likely benign (Oct 10, 2022) | criteria provided, multiple submitters, no conflicts |
| - GRCh37:
- Chr3:10078001
- GRCh38:
- Chr3:10036317
| FANCD2, LOC107303338 | | Fanconi anemia, Fanconi anemia complementation group D2 | Likely benign (Jan 7, 2022) | criteria provided, multiple submitters, no conflicts |
| - GRCh37:
- Chr3:10130246
- GRCh38:
- Chr3:10088562
| FANCD2, FANCD2OS | | Fanconi anemia, Fanconi anemia complementation group D2 | Benign/Likely benign (Oct 27, 2022) | criteria provided, multiple submitters, no conflicts |
| - GRCh37:
- Chr3:10128957
- GRCh38:
- Chr3:10087273
| FANCD2, FANCD2OS | | Fanconi anemia, Fanconi anemia complementation group D2 | Likely benign (Jan 14, 2022) | criteria provided, multiple submitters, no conflicts |
| - GRCh37:
- Chr3:10107190
- GRCh38:
- Chr3:10065506
| LOC107303338, FANCD2 | | Fanconi anemia, Fanconi anemia complementation group D2 | Benign/Likely benign (Oct 11, 2022) | criteria provided, multiple submitters, no conflicts |
| - GRCh37:
- Chr3:10081548
- GRCh38:
- Chr3:10039864
| FANCD2, LOC107303338 | | Fanconi anemia, Fanconi anemia complementation group D2 | Likely benign (Nov 1, 2022) | criteria provided, multiple submitters, no conflicts |
| - GRCh37:
- Chr3:10083289
- GRCh38:
- Chr3:10041605
| LOC107303338, FANCD2 | | Fanconi anemia complementation group D2, Fanconi anemia | Likely benign (Oct 21, 2022) | criteria provided, multiple submitters, no conflicts |
| - GRCh37:
- Chr3:10077953
- GRCh38:
- Chr3:10036269
| FANCD2, LOC107303338 | | Fanconi anemia complementation group D2, Fanconi anemia | Likely benign (Oct 3, 2022) | criteria provided, multiple submitters, no conflicts |
| - GRCh37:
- Chr3:10102103
- GRCh38:
- Chr3:10060419
| FANCD2, LOC107303338 | | Fanconi anemia complementation group D2, Fanconi anemia | Likely benign (Jul 19, 2022) | criteria provided, multiple submitters, no conflicts |
| - GRCh37:
- Chr3:10106409
- GRCh38:
- Chr3:10064725
| FANCD2, LOC107303338 | | Fanconi anemia, Fanconi anemia complementation group D2 | Likely benign (Sep 30, 2022) | criteria provided, multiple submitters, no conflicts |
| - GRCh37:
- Chr3:10116199
- GRCh38:
- Chr3:10074515
| LOC107303338, FANCD2 | | Fanconi anemia, Fanconi anemia complementation group D2 | Likely benign (Oct 27, 2022) | criteria provided, multiple submitters, no conflicts |
| - GRCh37:
- Chr3:10070407
- GRCh38:
- Chr3:10028723
| FANCD2 | | Fanconi anemia, Fanconi anemia complementation group D2 | Likely pathogenic (Feb 18, 2022) | criteria provided, multiple submitters, no conflicts |
| - GRCh37:
- Chr3:10108903
- GRCh38:
- Chr3:10067219
| FANCD2, LOC107303338 | A799D, A762D | Fanconi anemia complementation group D2, Fanconi anemia | Uncertain significance (Dec 7, 2021) | criteria provided, multiple submitters, no conflicts |
| - GRCh37:
- Chr3:10123017
- GRCh38:
- Chr3:10081333
| FANCD2, FANCD2OS | | not provided, Fanconi anemia, Fanconi anemia complementation group D2
| Uncertain significance (Sep 18, 2023) | criteria provided, multiple submitters, no conflicts |
| - GRCh37:
- Chr3:10116370
- GRCh38:
- Chr3:10074686
| FANCD2, LOC107303338 | | Fanconi anemia, Fanconi anemia complementation group D2 | Uncertain significance (Oct 10, 2021) | criteria provided, multiple submitters, no conflicts |
| - GRCh37:
- Chr3:10106108
- GRCh38:
- Chr3:10064424
| FANCD2, LOC107303338 | | Fanconi anemia, Fanconi anemia complementation group D2 | Uncertain significance (Dec 23, 2021) | criteria provided, multiple submitters, no conflicts |
| - GRCh37:
- Chr3:10123133
- GRCh38:
- Chr3:10081449
| FANCD2, FANCD2OS | H1070R, H1033R | Fanconi anemia, Fanconi anemia complementation group D2 | Uncertain significance (Feb 17, 2022) | criteria provided, multiple submitters, no conflicts |
| - GRCh37:
- Chr3:10085193
- GRCh38:
- Chr3:10043509
| FANCD2, LOC107303338 | G339S | Fanconi anemia, Fanconi anemia complementation group D2 | Uncertain significance (Aug 13, 2022) | criteria provided, multiple submitters, no conflicts |
| - GRCh37:
- Chr3:10102039
- GRCh38:
- Chr3:10060355
| FANCD2, LOC107303338 | I536T, I573T | Fanconi anemia complementation group D2, Fanconi anemia | Uncertain significance (Oct 24, 2022) | criteria provided, multiple submitters, no conflicts |
| - GRCh37:
- Chr3:10115066
- GRCh38:
- Chr3:10073382
| FANCD2, LOC107303338 | | Fanconi anemia, Fanconi anemia complementation group D2 | Uncertain significance (May 27, 2022) | criteria provided, multiple submitters, no conflicts |
| - GRCh37:
- Chr3:10105514-10105515
- GRCh38:
- Chr3:10063830-10063831
| FANCD2, LOC107303338 | Q586*, Q623* | Fanconi anemia, Fanconi anemia complementation group D2 | Pathogenic/Likely pathogenic (Mar 23, 2023) | criteria provided, multiple submitters, no conflicts |
| - GRCh37:
- Chr3:10130558
- GRCh38:
- Chr3:10088874
| FANCD2, FANCD2OS | I1203F, I1166F | Fanconi anemia, Fanconi anemia complementation group D2 | Uncertain significance (Mar 15, 2022) | criteria provided, multiple submitters, no conflicts |
| - GRCh37:
- Chr3:10128903
- GRCh38:
- Chr3:10087219
| FANCD2, FANCD2OS | I1141V, I1104V | Fanconi anemia, Fanconi anemia complementation group D2 | Uncertain significance (Mar 28, 2022) | criteria provided, multiple submitters, no conflicts |
| - GRCh37:
- Chr3:10128888
- GRCh38:
- Chr3:10087204
| FANCD2, FANCD2OS | R1099G, R1136G | Fanconi anemia complementation group D2, Fanconi anemia | Uncertain significance (Sep 2, 2021) | criteria provided, multiple submitters, no conflicts |
| - GRCh37:
- Chr3:10134996
- GRCh38:
- Chr3:10093312
| FANCD2OS, FANCD2 | V1293I, V1256I | Inborn genetic diseases, Fanconi anemia complementation group D2, Fanconi anemia
| Conflicting interpretations of pathogenicity (Sep 1, 2022) | criteria provided, conflicting interpretations |
| - GRCh37:
- Chr3:10140407
- GRCh38:
- Chr3:10098723
| FANCD2, FANCD2OS | E1360K, E1384K, E1397K | Fanconi anemia complementation group D2, Fanconi anemia | Uncertain significance (Apr 14, 2022) | criteria provided, multiple submitters, no conflicts |
| - GRCh37:
- Chr3:10084267
- GRCh38:
- Chr3:10042583
| FANCD2, LOC107303338 | L270V | Inborn genetic diseases, Fanconi anemia complementation group D2, Fanconi anemia
| Uncertain significance (Dec 19, 2022) | criteria provided, multiple submitters, no conflicts |
| - GRCh37:
- Chr3:10102090
- GRCh38:
- Chr3:10060406
| FANCD2, LOC107303338 | | Fanconi anemia complementation group D2, Fanconi anemia | Uncertain significance (Jul 21, 2022) | criteria provided, multiple submitters, no conflicts |
| - GRCh37:
- Chr3:10088364
- GRCh38:
- Chr3:10046680
| FANCD2, LOC107303338 | I412T | Fanconi anemia complementation group D2, Fanconi anemia | Uncertain significance (Apr 20, 2022) | criteria provided, multiple submitters, no conflicts |
| - GRCh37:
- Chr3:10076203
- GRCh38:
- Chr3:10034519
| FANCD2, LOC107303338 | H86Y | not specified, Fanconi anemia, Fanconi anemia complementation group D2
| Uncertain significance (Jun 9, 2022) | criteria provided, multiple submitters, no conflicts |
| - GRCh37:
- Chr3:10132062
- GRCh38:
- Chr3:10090378
| FANCD2, FANCD2OS | S1257L, S1220L | Fanconi anemia, Fanconi anemia complementation group D2 | Uncertain significance (Sep 26, 2022) | criteria provided, multiple submitters, no conflicts |
| - GRCh37:
- Chr3:10116239
- GRCh38:
- Chr3:10074555
| FANCD2, LOC107303338 | T877I, T914I | Fanconi anemia, Fanconi anemia complementation group D2 | Uncertain significance (Jul 9, 2022) | criteria provided, multiple submitters, no conflicts |
| - GRCh37:
- Chr3:10127497
- GRCh38:
- Chr3:10085813
| FANCD2, FANCD2OS | S1076G, S1039G | Fanconi anemia complementation group D2, Fanconi anemia | Uncertain significance (Apr 30, 2022) | criteria provided, multiple submitters, no conflicts |
| - GRCh37:
- Chr3:10085205
- GRCh38:
- Chr3:10043521
| FANCD2, LOC107303338 | I343V | Fanconi anemia complementation group D2, Fanconi anemia | Uncertain significance (Jan 1, 2022) | criteria provided, multiple submitters, no conflicts |
| - GRCh37:
- Chr3:10101973
- GRCh38:
- Chr3:10060289
| FANCD2, LOC107303338 | | Fanconi anemia, Fanconi anemia complementation group D2 | Uncertain significance (Apr 12, 2022) | criteria provided, multiple submitters, no conflicts |
| - GRCh37:
- Chr3:10130193
- GRCh38:
- Chr3:10088509
| FANCD2, FANCD2OS | N1139S, N1176S | Fanconi anemia complementation group D2, Fanconi anemia | Uncertain significance (Aug 30, 2022) | criteria provided, multiple submitters, no conflicts |
| - GRCh37:
- Chr3:10122791
- GRCh38:
- Chr3:10081107
| FANCD2 | G995E, G958E | Fanconi anemia, Fanconi anemia complementation group D2 | Uncertain significance (Apr 15, 2022) | criteria provided, multiple submitters, no conflicts |
| - GRCh37:
- Chr3:10081002
- GRCh38:
- Chr3:10039318
| FANCD2, LOC107303338 | | not specified, Fanconi anemia complementation group D2 | Uncertain significance (Nov 17, 2021) | criteria provided, multiple submitters, no conflicts |
| - GRCh37:
- Chr3:10084356
- GRCh38:
- Chr3:10042672
| FANCD2, LOC107303338 | | not specified, Fanconi anemia complementation group D2 | Likely benign (Mar 2, 2022) | criteria provided, multiple submitters, no conflicts |
| - GRCh37:
- Chr3:10107088
- GRCh38:
- Chr3:10065404
| FANCD2, LOC107303338 | P690S, P727S | Fanconi anemia, Fanconi anemia complementation group D2 | Uncertain significance (Aug 29, 2022) | criteria provided, multiple submitters, no conflicts |
| - GRCh37:
- Chr3:10134984
- GRCh38:
- Chr3:10093300
| FANCD2, FANCD2OS | P1252S, P1289S | not specified, Fanconi anemia complementation group D2 | Uncertain significance (Aug 15, 2023) | criteria provided, multiple submitters, no conflicts |
| - GRCh37:
- Chr3:10123127
- GRCh38:
- Chr3:10081443
| FANCD2, FANCD2OS | I1031T, I1068T | Fanconi anemia complementation group D2 | Uncertain significance (Jul 24, 2021) | criteria provided, single submitter |
| - GRCh37:
- Chr3:10133904
- GRCh38:
- Chr3:10092220
| FANCD2, FANCD2OS | R1236*, R1273* | Fanconi anemia, Fanconi anemia complementation group D2 | Pathogenic/Likely pathogenic (Mar 14, 2023) | criteria provided, multiple submitters, no conflicts |
| - GRCh37:
- Chr3:10128858
- GRCh38:
- Chr3:10087174
| FANCD2, FANCD2OS | S1090fs, S1127fs | Fanconi anemia complementation group D2 | Likely pathogenic (Jun 28, 2019) | criteria provided, single submitter |
| - GRCh37:
- Chr3:10074539
- GRCh38:
- Chr3:10032855
| FANCD2, LOC107303338 | K31fs | Fanconi anemia complementation group D2 | Likely pathogenic (May 4, 2022) | criteria provided, single submitter |
| - GRCh37:
- Chr3:10080976
- GRCh38:
- Chr3:10039292
| LOC107303338, FANCD2 | E169* | Fanconi anemia complementation group D2 | Likely pathogenic (Feb 2, 2021) | criteria provided, single submitter |
| - GRCh37:
- Chr3:10107658
- GRCh38:
- Chr3:10065974
| LOC107303338, FANCD2 | R757*, R794* | Fanconi anemia, Fanconi anemia complementation group D2 | Pathogenic/Likely pathogenic (Sep 5, 2022) | criteria provided, multiple submitters, no conflicts |
| - GRCh37:
- Chr3:10130166
- GRCh38:
- Chr3:10088482
| FANCD2, FANCD2OS | W1130*, W1167* | Fanconi anemia complementation group D2 | Pathogenic (Mar 25, 2019) | criteria provided, single submitter |
| - GRCh37:
- Chr3:10122782
- GRCh38:
- Chr3:10081098
| FANCD2 | | Fanconi anemia complementation group D2 | Pathogenic (Jun 10, 2019) | criteria provided, single submitter |
| - GRCh37:
- Chr3:10127570-10127571
- GRCh38:
- Chr3:10085886-10085887
| FANCD2OS, FANCD2 | Q1063fs, Q1100fs | Fanconi anemia, Fanconi anemia complementation group D2 | Pathogenic/Likely pathogenic (Aug 4, 2022) | criteria provided, multiple submitters, no conflicts |
| - GRCh37:
- Chr3:10074547-10074550
- GRCh38:
- Chr3:10032863-10032866
| LOC107303338, FANCD2 | K33fs | Fanconi anemia complementation group D2 | Pathogenic (Nov 16, 2021) | criteria provided, multiple submitters, no conflicts |
| - GRCh37:
- Chr3:10106551
- GRCh38:
- Chr3:10064867
| LOC107303338, FANCD2 | G684fs, G721fs | Fanconi anemia complementation group D2 | Pathogenic (May 15, 2019) | criteria provided, single submitter |
| - GRCh37:
- Chr3:10076174
- GRCh38:
- Chr3:10034490
| FANCD2, LOC107303338 | K77fs | Fanconi anemia complementation group D2 | Likely pathogenic (Mar 11, 2022) | criteria provided, single submitter |
| - GRCh37:
- Chr3:10091124
- GRCh38:
- Chr3:10049440
| FANCD2, LOC107303338 | D494Y | not provided, Fanconi anemia complementation group D2 | Uncertain significance (Dec 20, 2021) | criteria provided, multiple submitters, no conflicts |
| - GRCh37:
- Chr3:10088351
- GRCh38:
- Chr3:10046667
| FANCD2, LOC107303338 | R408* | Fanconi anemia complementation group D2, Fanconi anemia | Conflicting interpretations of pathogenicity (Dec 8, 2021) | criteria provided, conflicting interpretations |
| - GRCh37:
- Chr3:10119886
- GRCh38:
- Chr3:10078202
| FANCD2, LOC107303338 | | not specified, Fanconi anemia, Fanconi anemia complementation group D2
| Conflicting interpretations of pathogenicity (Jun 8, 2021) | criteria provided, conflicting interpretations |
| - GRCh37:
- Chr3:10089599
- GRCh38:
- Chr3:10047915
| FANCD2, LOC107303338 | | Fanconi anemia complementation group D2 | Likely pathogenic (Jun 30, 2021) | criteria provided, single submitter |
| - GRCh37:
- Chr3:10114666-10114667
- GRCh38:
- Chr3:10072982-10072983
| LOC107303338, FANCD2 | | Fanconi anemia, Fanconi anemia complementation group D2 | Conflicting interpretations of pathogenicity (Jun 14, 2022) | criteria provided, conflicting interpretations |
| - GRCh37:
- Chr3:10076406-10076407
- GRCh38:
- Chr3:10034722-10034723
| FANCD2, LOC107303338 | E101fs | Fanconi anemia complementation group D2 | Likely pathogenic (Jun 30, 2021) | criteria provided, single submitter |
| - GRCh37:
- Chr3:10123050
- GRCh38:
- Chr3:10081366
| FANCD2OS, FANCD2 | | Fanconi anemia, Fanconi anemia complementation group D2 | Likely benign (Nov 4, 2021) | criteria provided, multiple submitters, no conflicts |
| - GRCh37:
- Chr3:10140424
- GRCh38:
- Chr3:10098740
| FANCD2, FANCD2OS | | Fanconi anemia complementation group D2, Fanconi anemia | Benign/Likely benign (Jul 6, 2022) | criteria provided, multiple submitters, no conflicts |
| - GRCh37:
- Chr3:10094139
- GRCh38:
- Chr3:10052455
| FANCD2, LOC107303338 | | Fanconi anemia complementation group D2, Fanconi anemia | Likely benign (Mar 27, 2022) | criteria provided, multiple submitters, no conflicts |
| - GRCh37:
- Chr3:10084234
- GRCh38:
- Chr3:10042550
| FANCD2, LOC107303338 | | Fanconi anemia, Fanconi anemia complementation group D2 | Likely benign (Apr 25, 2022) | criteria provided, multiple submitters, no conflicts |
| - GRCh37:
- Chr3:10116252
- GRCh38:
- Chr3:10074568
| FANCD2, LOC107303338 | | Fanconi anemia, Fanconi anemia complementation group D2 | Benign/Likely benign (Oct 3, 2022) | criteria provided, multiple submitters, no conflicts |
| - GRCh37:
- Chr3:10116249
- GRCh38:
- Chr3:10074565
| FANCD2, LOC107303338 | | Fanconi anemia complementation group D2, Fanconi anemia | Likely benign (Apr 10, 2022) | criteria provided, multiple submitters, no conflicts |
| - GRCh37:
- Chr3:10091054
- GRCh38:
- Chr3:10049370
| FANCD2, LOC107303338 | | Fanconi anemia, Fanconi anemia complementation group D2 | Likely benign (Aug 16, 2022) | criteria provided, multiple submitters, no conflicts |
| - GRCh37:
- Chr3:10116343
- GRCh38:
- Chr3:10074659
| FANCD2, LOC107303338 | E912*, E949* | Fanconi anemia, Fanconi anemia complementation group D2 | Pathogenic/Likely pathogenic (Nov 11, 2021) | criteria provided, multiple submitters, no conflicts |
| - GRCh37:
- Chr3:10083317-10083318
- GRCh38:
- Chr3:10041633-10041634
| FANCD2, LOC107303338 | I236fs | Fanconi anemia, Fanconi anemia complementation group D2 | Pathogenic/Likely pathogenic (Jul 29, 2021) | criteria provided, multiple submitters, no conflicts |
| - GRCh37:
- Chr3:10109003
- GRCh38:
- Chr3:10067319
| FANCD2, LOC107303338 | | Fanconi anemia, Fanconi anemia complementation group D2 | Likely pathogenic (Apr 10, 2022) | criteria provided, multiple submitters, no conflicts |
| - GRCh37:
- Chr3:10074573
- GRCh38:
- Chr3:10032889
| FANCD2, LOC107303338 | V41A | Fanconi anemia, Fanconi anemia complementation group D2 | Uncertain significance (Oct 19, 2022) | criteria provided, multiple submitters, no conflicts |
| - GRCh37:
- Chr3:10107623
- GRCh38:
- Chr3:10065939
| FANCD2, LOC107303338 | M745T, M782T | Fanconi anemia complementation group D2, Fanconi anemia | Uncertain significance (Jun 16, 2022) | criteria provided, multiple submitters, no conflicts |
| - GRCh37:
- Chr3:10074554
- GRCh38:
- Chr3:10032870
| FANCD2, LOC107303338 | S35P | Fanconi anemia | Uncertain significance (Aug 30, 2021) | criteria provided, single submitter |
| - GRCh37:
- Chr3:10140568
- GRCh38:
- Chr3:10098884
| FANCD2, FANCD2OS | W1437*, W1450* | not specified, Fanconi anemia, Fanconi anemia complementation group D2
| Uncertain significance (Mar 29, 2022) | criteria provided, multiple submitters, no conflicts |
| - GRCh37:
- Chr3:10081439
- GRCh38:
- Chr3:10039755
| FANCD2, LOC107303338 | I202T | Fanconi anemia complementation group D2, Fanconi anemia | Uncertain significance (Aug 20, 2021) | criteria provided, multiple submitters, no conflicts |
| - GRCh37:
- Chr3:10105543
- GRCh38:
- Chr3:10063859
| FANCD2, LOC107303338 | Y632C, Y595C | Fanconi anemia complementation group D2, Fanconi anemia | Uncertain significance (Sep 17, 2022) | criteria provided, multiple submitters, no conflicts |
| - GRCh37:
- Chr3:10116275
- GRCh38:
- Chr3:10074591
| FANCD2, LOC107303338 | R926L, R889L | Fanconi anemia complementation group D2 | Uncertain significance (Aug 15, 2018) | criteria provided, single submitter |
| - GRCh37:
- Chr3:10107112
- GRCh38:
- Chr3:10065428
| LOC107303338, FANCD2 | R735W, R698W | Fanconi anemia, Fanconi anemia complementation group D2 | Uncertain significance (Aug 24, 2021) | criteria provided, multiple submitters, no conflicts |
| - GRCh37:
- Chr3:10107629
- GRCh38:
- Chr3:10065945
| FANCD2, LOC107303338 | S747F, S784F | Ovarian cancer, Fanconi anemia, Fanconi anemia complementation group D2
| Conflicting interpretations of pathogenicity (Jun 2, 2022) | criteria provided, conflicting interpretations |
| - GRCh37:
- Chr3:10135980
- GRCh38:
- Chr3:10094296
| FANCD2, FANCD2OS | R1262H, R1286H, R1299H | Inborn genetic diseases, Fanconi anemia, Fanconi anemia complementation group D2
| Uncertain significance (Mar 12, 2022) | criteria provided, multiple submitters, no conflicts |
| - GRCh37:
- Chr3:10123156
- GRCh38:
- Chr3:10081472
| FANCD2, FANCD2OS | | Fanconi anemia complementation group D2, Fanconi anemia | Uncertain significance (Feb 25, 2022) | criteria provided, multiple submitters, no conflicts |
| - GRCh37:
- Chr3:10106421
- GRCh38:
- Chr3:10064737
| FANCD2, LOC107303338 | P640L, P677L | Fanconi anemia complementation group D2, Fanconi anemia | Uncertain significance (Nov 15, 2021) | criteria provided, multiple submitters, no conflicts |
| - GRCh37:
- Chr3:10140536
- GRCh38:
- Chr3:10098852
| FANCD2, FANCD2OS | G1427S, G1440S | Fanconi anemia, Fanconi anemia complementation group D2 | Uncertain significance (Aug 6, 2022) | criteria provided, multiple submitters, no conflicts |